Cargando…
A small molecule CFTR potentiator restores ATP‐dependent channel gating to the cystic fibrosis mutant G551D‐CFTR
BACKGROUND AND PURPOSE: Cystic fibrosis transmembrane conductance regulator (CFTR) potentiators are small molecules developed to treat the genetic disease cystic fibrosis (CF). They interact directly with CFTR Cl(−) channels at the plasma membrane to enhance channel gating. Here, we investigate the...
Autores principales: | Liu, Jia, Berg, Allison P., Wang, Yiting, Jantarajit, Walailak, Sutcliffe, Katy J., Stevens, Edward B., Cao, Lishuang, Pregel, Marko J., Sheppard, David N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304199/ https://www.ncbi.nlm.nih.gov/pubmed/34644413 http://dx.doi.org/10.1111/bph.15709 |
Ejemplares similares
-
CFTR Gating I: Characterization of the ATP-dependent Gating of a Phosphorylation-independent CFTR Channel (ΔR-CFTR)
por: Bompadre, Silvia G., et al.
Publicado: (2005) -
Cystic Fibrosis Transmembrane Conductance Regulator
(CFTR) Potentiators Protect G551D but Not ΔF508 CFTR from Thermal
Instability
por: Liu, Xuehong, et al.
Publicado: (2014) -
Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
por: Stefano, Daniela De, et al.
Publicado: (2014) -
On the Mechanism of MgATP-dependent Gating of CFTR Cl(−) Channels
por: Vergani, Paola, et al.
Publicado: (2003) -
Regulation of CFTR Cl- channel gating by ADP and ATP analogues
Publicado: (1995)